February 26, 2013 — New and updated evidence-based guidelines to help healthcare providers choose the most appropriate medical imaging exam or radiation therapy for a patient’s clinical condition are now available via the latest version of the American College of Radiology appropriateness criteria. These continually updated criteria are a national standard developed by expert panels of physicians from many different medical specialties.

In the latest version, the ACR updated 23 appropriateness criteria topics and added four new criteria — pulmonary hypertension; renal transplant dysfunction; management of locoregionally advanced squamous cell carcinoma of the vulva; and treatment of Stage I T1 glottic cancer. ACR appropriateness criteria guide physicians when ordering exams and help ensure that patients get the right scan or therapy for the right indication. The criteria have also been shown to improve quality, reduce unnecessary exams and lower costs. 

“Choosing the most appropriate radiation therapy strategy is essential to the effective and safe treatment of many cancer patients. Use of ACR appropriateness criteria can aid physicians in doing so by providing the latest evidence-based approach for a wide variety of radiotherapy issues,” said Benjamin Movsas, M.D., FACR, chair of the ACR Committee on Radiation Oncology Appropriateness Criteria.

ACR appropriateness criteria provide a tool for more effective clinical decision making to help ensure that imaging is neither over nor underutilized. The guidelines are developed by expert panels in diagnostic imaging, interventional radiology and radiation oncology. Each panel includes leaders in radiology and other specialties. Currently, there are 186 topics with over 900 variants available.

“ACR appropriateness criteria are the most comprehensive evidence-based guidelines available for selection of diagnostic imaging and image-guided interventional procedures. Not only do these guidelines aid referring physicians and other providers in choosing the most appropriate diagnostic imaging and interventional procedures for a wide variety of clinical conditions, they can reduce unnecessary patient and population exposure to radiation, a growing concern of many Americans. I urge every provider to familiarize themselves with these guidelines before making a diagnostic imaging or image-guided interventional treatment decision,” said E. Kent Yucel, M.D., FACR, chair of the ACR Committee on Diagnostic Imaging and Interventional Radiology Appropriateness Criteria.

For more information: acr.org/Quality-Safety/Appropriateness-Criteria

 

 


Related Content

News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
News | Computed Tomography (CT)

SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...

Time August 06, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
Feature | Computed Tomography (CT) | By Melinda Taschetta-Millane

In the ever-evolving landscape of medical imaging, computed tomography (CT) stands out as a cornerstone technology ...

Time July 30, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | Breast Imaging

July 29, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the ...

Time July 29, 2024
arrow
News | Breast Imaging

July 29, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time July 29, 2024
arrow
Feature | Radiology Business | By Christine Book

Across the healthcare industry, and, notably, throughout the radiology community in just the past few years, the focus ...

Time July 26, 2024
arrow
Feature | Mobile C-Arms | By Melinda Taschetta-Millane

Mobile C-arms continue to revolutionize medical imaging, offering versatility, mobility and real-time visualization ...

Time July 26, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
Subscribe Now